Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (21-30 of 272) with videos related to

Pageof 28
Sort By:
The New England Journal of Medicine|August 12, 2011
Early prostate cancer--treat or watch?Michael Froehner, Manfred P Wirth
European Urology|September 10, 2014
Simultaneous targeting of the Akt and androgen receptor pathwaysManfred P Wirth, Michael Froehner
International Journal of Cancer|March 8, 2014
Socio-economic deprivation and cancer survival in GermanyMichael Froehner, Manfred P Wirth
European Urology|March 14, 2015
Prostate-specific antigen pox virus vaccination for recurrent prostate cancerManfred P Wirth, Michael Froehner
European Urology|March 19, 2011
Words of wisdom. Re: mortality results from the Göteborg randomised population-based prostate-cancer screening trialManfred P Wirth, Michael Froehner
European Urology|February 16, 2013
What really matters is rarely measured: outcome of routine care and patient-reported outcomesManfred P Wirth, Johannes Huber
European Urology|June 11, 2013
Predictive significance of confirmation biopsies in patients on active surveillanceManfred P Wirth, Michael Froehner
Urologia Internationalis|January 23, 2002
Perspectives in adjuvant treatment of prostate cancerManfred P Wirth, Michael Froehner
European Urology|March 16, 2010
Radical prostatectomy-only centers: the future in genitourinary surgery?Manfred P Wirth, Michael Froehner
International Journal of Radiation Oncology, Biology, Physics|June 15, 2010
Response to "The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients." (Int J Radiat Oncol Biol Phys 2010;76:342-348)Michael Froehner, Manfred P Wirth
Pageof 28

Showing results (21-30 of 272) with videos related to

Sort By:
Pageof 28
The New England Journal of Medicine|August 12, 2011
Early prostate cancer--treat or watch?Michael Froehner, Manfred P Wirth
European Urology|September 10, 2014
Simultaneous targeting of the Akt and androgen receptor pathwaysManfred P Wirth, Michael Froehner
International Journal of Cancer|March 8, 2014
Socio-economic deprivation and cancer survival in GermanyMichael Froehner, Manfred P Wirth
European Urology|March 14, 2015
Prostate-specific antigen pox virus vaccination for recurrent prostate cancerManfred P Wirth, Michael Froehner
European Urology|March 19, 2011
Words of wisdom. Re: mortality results from the Göteborg randomised population-based prostate-cancer screening trialManfred P Wirth, Michael Froehner
European Urology|February 16, 2013
What really matters is rarely measured: outcome of routine care and patient-reported outcomesManfred P Wirth, Johannes Huber
European Urology|June 11, 2013
Predictive significance of confirmation biopsies in patients on active surveillanceManfred P Wirth, Michael Froehner
Urologia Internationalis|January 23, 2002
Perspectives in adjuvant treatment of prostate cancerManfred P Wirth, Michael Froehner
European Urology|March 16, 2010
Radical prostatectomy-only centers: the future in genitourinary surgery?Manfred P Wirth, Michael Froehner
International Journal of Radiation Oncology, Biology, Physics|June 15, 2010
Response to "The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients." (Int J Radiat Oncol Biol Phys 2010;76:342-348)Michael Froehner, Manfred P Wirth
Pageof 28